BKV Corp Form 144: insider plans sale of 178,281 shares

BKV Corp insider activity shows a planned sale of 178,281 common shares through broker Charles Schwab & Co., Inc., with an aggregate market value of $4,998,447.

Rhea-AI Filing Summary

BKV Corp insider activity shows a planned sale of 178,281 common shares through broker Charles Schwab & Co., Inc., with an aggregate market value of $4,998,447. These shares trade on the NYSE, and the approximate date of sale is listed as 11/17/2025, with 89,970,076 common shares outstanding as a baseline figure. The securities to be sold were acquired on 08/22/2024 via a restricted stock lapse as equity compensation.

During the prior three months, the same seller, Christopher P. Kalnin, reported additional BKV Corp share sales: 100,000 shares on 11/10/2025 for gross proceeds of $2,615,856, 100,000 shares on 11/11/2025 for $2,713,138, and 21,719 shares on 11/14/2025 for $608,201. The seller represents that he is not aware of any undisclosed material adverse information about BKV Corp’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BKV Corp's Form 144 filing disclose?

The Form 144 for BKV Corp (BKV) discloses a planned sale of 178,281 common shares by an insider, with an aggregate market value of $4,998,447, to be sold on the NYSE through Charles Schwab & Co., Inc.

How many BKV Corp shares are being sold and when is the planned sale date?

The filing reports a planned sale of 178,281 common shares of BKV Corp, with an approximate sale date of 11/17/2025, executed on the NYSE.

How and when were the BKV Corp shares to be sold acquired?

The 178,281 BKV Corp common shares were acquired on 08/22/2024 through a restricted stock lapse, described as equity compensation, from BKV Corp.

What recent BKV Corp share sales by the insider are reported in the past 3 months?

The insider, Christopher P. Kalnin, reported BKV Corp share sales of 100,000 shares on 11/10/2025 for $2,615,856, 100,000 shares on 11/11/2025 for $2,713,138, and 21,719 shares on 11/14/2025 for $608,201.

How many BKV Corp shares are outstanding according to this Form 144?

The Form 144 states that there are 89,970,076 common shares of BKV Corp outstanding, providing a baseline context for the reported insider sales.

Which broker is handling the BKV Corp Form 144 share sale?

The planned sale of 178,281 BKV Corp common shares is to be executed through Charles Schwab & Co., Inc., located at 3000 Schwab Way, Westlake, TX 76262.

What representation does the seller make about information on BKV Corp?

The seller represents that he does not know any material adverse information about BKV Corp’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/17/2025 - 04:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001953932
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BKV Corp
SEC File Number	001-42282
Address of Issuer	1200 17TH ST., STE 2100 DENVER COLORADO 80202
Phone	(720) 375-9680
Name of Person for Whose Account the Securities are To Be Sold	Kalnin Christopher P
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	178281	4998447.00	89970076	11/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2024	Restricted Stock Lapse - See Remarks	BKV Corp			178281	08/22/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher P Kalnin 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	11/10/2025	100000	2615856.00
Christopher P Kalnin 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	11/11/2025	100000	2713138.00
Christopher P Kalnin 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	11/14/2025	21719	608201.00

144: Remarks and Signature

Remarks	Shares on this filing may be sold over various dates.
Date of Notice	11/17/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Christopher P Kalnin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)